Last updated on February 2018
Study of the Effects of Fabrazyme Treatment on Lactation and Infants
Brief description of study
The study will last for up to 2 years (24 months). Full participation for both mother and infant is 24 months, full participation of mother and development of infant is 24 months, while full participation of mother and no infant participation is 6 months
Detailed Study Description
NOTE: Estimated Enrollment: 10 mothers and up to 10 infants
Clinical Study Identifier: NCT00230607